Cardiology News and Highlights - September 2026

Awards and Honors
Michelle Albert, MD, MPH, was selected by the UCSF School of Medicine to deliver the UCSF Physician Declaration at the annual White Coat Ceremony.
Megan McLaughlin, MD, received the 2026 UCSF Emerging Women's Health Research Scholar Award, recognizing her work and commitment to women's health research.
Appointments and Promotions
Yousif Ahmad, MD, PhD, was promoted from Assistant Professor to Associate Professor.
James Pirruccello, MD, was promoted from Assistant Professor to Associate Professor.
Research Highlights
Theodore Abraham, MD, received an award from Braveheart Bio to support BHB-1893-301, a Phase 3, multi-region, multicenter, randomized, double-blind trial evaluating the efficacy and safety of BHB-1893 compared with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy.
Richard Baylis, MD, PhD, received the 2026 Hellman Family Clinical-Translational Research Development Award from the ImmunoX Research Committee for the proposal, “Leveraging the UCSF Myocarditis Center to Define Human Myocarditis Immunobiology.” The award provides $100,000 over two years to support the research.
Javid Moslehi, MD, will serve as North American coordinator of CoeurTCR, an international research network awarded $9 million by the Leducq Foundation to investigate immune mechanisms underlying myocarditis and other inflammatory heart muscle diseases. The network will seek to identify the T cells and cardiac antigens involved in disease, with the goal of informing more targeted therapies that preserve broader immune function.
Zian Tseng, MD, MAS, and the POST SCD team, were featured in UCSF Magazine for their research examining the causes of sudden cardiac death. Drawing on a 15-year UCSF investigation, the team's work provides new evidence about why individuals may die suddenly and unexpectedly, challenging longstanding assumptions about the causes of sudden cardiac death.
In the News
Nadine Wlasiuk, was featured in an interview with EP Lab Digest focused on the role of advanced practice providers in electrophysiology practices. The interview highlights her perspective on the contributions of advanced practice providers to EP care and practice operations.
Leadership and Professional Contributions
Gregory Marcus, MD, MAS, served as vice chair of the 2026 AHA/ACC Clinical Performance and Quality Measures for Patients with Atrial Fibrillation, recently published in JACC and Circulation: Cardiovascular Quality and Outcomes.
Daniel Morin, MD, MPH, chaired the Heart Rhythm Society committee that developed the “2026 HRS/PACES Scientific Statement on the Use of Antiarrhythmic Drugs in Understudied Clinical Scenarios,” recently published in Heart Rhythm. The statement provides guidance on antiarrhythmic drug therapy in clinical scenarios where evidence and established recommendations are limited.
Podcasts and Media
Rita Redberg, MD, MSc, joined Elsevier's Raise the Line podcast to discuss high-value care and how clinicians and patients can weigh the benefits and risks of common medical tests and procedures. The conversation also highlights her research on the safety and effectiveness of high-risk cardiovascular devices and her role in launching the Less is More series in JAMA Internal Medicine.
Patient Reviews
Chris Barnett, MD
“Dr. Chris Barnett spent considerable time with me and my husband. I'm so grateful to have such a kind and compassionate physician that also specializes in my disease of pulmonary hypertension.”
Anna Beyer, MD
“Dr. Anna Beyer is thorough and very caring. Discussed and explains any questions I have.”
Christopher Lee, MD
“Dr. Chrisopher Lee is simply the best. I look forward to my visits with him and I always feel that he cares about me as a person.”
Atif Qasim, MD
“Dr. Atif Qasim is an exceptional healthcare provider. He listens and he has excellent communication skills. He is kind and empathetic. I can only rave about him.”
Community and Events


NorCal O2 Breathe Walk: Members of the UCSF Pulmonary Hypertension Clinic joined 122 participants to support the Pulmonary Hypertension Association. The event surpassed its $20,000 fundraising goal.